Indeed, the impairment of the IRS1/2/PI3K/Akt pathway (triggering insulin signaling) leads to the loss of pro-angiogenic, anti-oxidative and anti-inflammatory actions in genetically obese Zucker rats [61] and studies as such should also be performed in the brain after stroke. The gene discussed is AKT1; the disease is Stroke.